{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:02:31Z","timestamp":1790172151776,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T00:00:00Z","timestamp":1531267200000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.bjid.2018.06.005","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T03:37:16Z","timestamp":1532403436000},"page":"311-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Helicobacter pylori eradication: influence of interleukin-1beta \u201331 C\/T polymorphism"],"prefix":"10.1016","volume":"22","author":[{"given":"T\u00e1ssia Flores","family":"Rech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Edmundo","family":"Mazzoleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Mazzoleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fernando de Magalh\u00e3es","family":"Francesconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Becker","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3156-9382","authenticated-orcid":false,"given":"Rafael Tomoya","family":"Michita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Dreher","family":"Nabinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias Cancian","family":"Milbradt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronaldo Jo\u00e3o Spinato","family":"Torresini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1122-8468","authenticated-orcid":false,"given":"Daniel","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2018.06.005_bib0005","doi-asserted-by":"crossref","first-page":"568","DOI":"10.3760\/cma.j.issn.0366-6999.20132708","article-title":"Helicobacter pylori infection: an overview in 2013, focus on therapy","volume":"127","author":"Cui","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.bjid.2018.06.005_bib0010","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bj.2015.06.002","article-title":"Helicobacter pylori infection: an overview of bacterial virulence factors and pathogenesis","volume":"39","author":"Kao","year":"2016","journal-title":"Biomed J"},{"key":"10.1016\/j.bjid.2018.06.005_bib0015","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jconrel.2014.06.020","article-title":"Eradication of Helicobacter pylori: past, present and future","volume":"189","author":"Lopes","year":"2014","journal-title":"J Control Release"},{"issue":"Suppl. 1","key":"10.1016\/j.bjid.2018.06.005_bib0020","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/hel.12071","article-title":"Diagnosis and epidemiology of Helicobacter pylori infection","volume":"18","author":"Calvet","year":"2013","journal-title":"Helicobacter"},{"key":"10.1016\/j.bjid.2018.06.005_bib0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10552-012-0117-5","article-title":"Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701)","volume":"24","author":"Porras","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"Suppl. 1","key":"10.1016\/j.bjid.2018.06.005_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hel.12250","article-title":"Epidemiology and diagnosis of Helicobacter pylori infection","volume":"20","author":"Mentis","year":"2015","journal-title":"Helicobacter"},{"key":"10.1016\/j.bjid.2018.06.005_bib0035","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1186\/1471-2458-14-915","article-title":"Helicobacter pylori infection in pregnant women in four districts of Uganda: role of geographic location, education and water sources","volume":"14","author":"Baingana","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bjid.2018.06.005_bib0040","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrgastro.2014.99","article-title":"Helicobacter pylori: perspectives and time trends","volume":"11","author":"Malfertheiner","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2018.06.005_bib0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrgastro.2013.9","article-title":"Helicobacter pylori infection in functional dyspepsia","volume":"10","author":"Suzuki","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2018.06.005_bib0050","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3748\/wjg.v20.i3.699","article-title":"Helicobacter pylori: future perspectives in therapy reflecting three decades of experience","volume":"20","author":"Kanizaj","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.bjid.2018.06.005_bib0055","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/1751-2980.12054","article-title":"The significance of virulence factors in Helicobacter pylori","volume":"14","author":"Shiota","year":"2013","journal-title":"J Dig Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.bjid.2018.06.005_bib0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1440-1746.2011.06633.x","article-title":"Current understanding of pathogenesis of functional dyspepsia","volume":"26","author":"Miwa","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2018.06.005_bib0065","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/MOG.0b013e32834b7ca8","article-title":"Functional dyspepsia","volume":"27","author":"Tack","year":"2011","journal-title":"Curr Opin Gastroenterol."},{"key":"10.1016\/j.bjid.2018.06.005_bib0070","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal disorders","volume":"150","author":"Stanghellini","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bjid.2018.06.005_bib0075","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection \u2013 the Maastricht IV\/ Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.bjid.2018.06.005_bib0080","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3904\/kjim.2016.091","article-title":"Functional dyspepsia: new insights into pathogenesis and therapy","volume":"31","author":"Talley","year":"2016","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.bjid.2018.06.005_bib0085","doi-asserted-by":"crossref","DOI":"10.1590\/S0004-28032013005000001","article-title":"3rd Brazilian Consensus on Helicobacter pylori","volume":"50","author":"Coelho","year":"2013","journal-title":"Arq Gastroenterol."},{"key":"10.1016\/j.bjid.2018.06.005_bib0090","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1523-5378.1999.99299.x","article-title":"Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin","volume":"4","author":"Kamada","year":"1999","journal-title":"Helicobacter"},{"key":"10.1016\/j.bjid.2018.06.005_bib0095","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1111\/j.1440-1746.2009.06047.x","article-title":"Influence of inflammatory cytokine polymorphisms on eradication rates of Helicobacter pylori","volume":"24","author":"Sugimoto","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2018.06.005_bib0100","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00005-009-0007-z","article-title":"Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy","volume":"57","author":"Sugimoto","year":"2009","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.bjid.2018.06.005_bib0105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/35006081","article-title":"Interleukin-1 polymorphisms associated with increased risk of gastric cancer","volume":"404","author":"El-Omar","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.bjid.2018.06.005_bib0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1751-2980.2009.00380.x","article-title":"Helicobacter pylori infection, host genetics and gastric cancer","volume":"10","author":"Shanks","year":"2009","journal-title":"J Dig Dis"},{"key":"10.1016\/j.bjid.2018.06.005_bib0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2004.07.012","article-title":"Interleukin-1B gene promoter variants are associated with an increased risk of gastric cancer in a Chinese population","volume":"215","author":"Yang","year":"2004","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bjid.2018.06.005_bib0120","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/gast.2002.34156","article-title":"Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan","volume":"123","author":"Furuta","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bjid.2018.06.005_bib0125","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1053\/gast.2002.37043","article-title":"Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection","volume":"123","author":"Hwang","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bjid.2018.06.005_bib0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0002-9343(01)01036-1","article-title":"Effect of genotypic differences in interleukin-1 beta on gastric acid secretion in Japanese patients infected with Helicobacter pylori","volume":"112","author":"Furuta","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.bjid.2018.06.005_bib0135","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7150\/ijms.3.135","article-title":"Eradication rate of Helicobacter pylori according to genotypes of CYP2C19, IL-1B, and TNF-A","volume":"3","author":"Ishida","year":"2006","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.bjid.2018.06.005_bib0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clpt.2006.03.007","article-title":"Influences of proinflammatory and anti-inflammatory cytokine polymorphisms on eradication rates of clarithromycin-sensitive strains of Helicobacter pylori by triple therapy","volume":"80","author":"Sugimoto","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.bjid.2018.06.005_bib0145","first-page":"2403","article-title":"Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection","volume":"98","author":"Take","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.bjid.2018.06.005_bib0150","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1007\/s11605-007-0246-4","article-title":"Clarithromycin resistance, tumor necrosis factor alpha gene polymorphism and mucosal inflammation affect H. pylori eradication success","volume":"11","author":"Zambon","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.bjid.2018.06.005_bib0155","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/j.1365-2710.2009.01140.x","article-title":"The effect of cytochrome P2C19 and interleukin-1 polymorphisms on H. pylori eradication rate of 1-week triple therapy with omeprazole or rabeprazole, amoxycillin and clarithromycin in Chinese people","volume":"35","author":"Zhang","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.bjid.2018.06.005_bib0160","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/archinternmed.2011.533","article-title":"Helicobacter pylori eradication in functional dyspepsia: HEROES trial","volume":"171","author":"Mazzoleni","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.bjid.2018.06.005_bib0165","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1053\/j.gastro.2005.11.059","article-title":"Functional gastroduodenal disorders","volume":"130","author":"Tack","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bjid.2018.06.005_bib0170","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1093\/nar\/19.19.5444","article-title":"A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies","volume":"19","author":"Lahiri","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.bjid.2018.06.005_bib0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-5573-8-1","article-title":"WINPEPI updated: computer programs for epidemiologists, and their teaching potential","volume":"8","author":"Abramson","year":"2011","journal-title":"Epidemiol Perspect Innov"},{"key":"10.1016\/j.bjid.2018.06.005_bib0180","first-page":"1156","article-title":"The first-line eradication rate for Helicobacter pylori infection in functional dyspepsia patients","volume":"3","author":"Matsuhisa","year":"2014","journal-title":"J GHR"},{"key":"10.1016\/j.bjid.2018.06.005_bib0185","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/gut.46.3.321","article-title":"Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment","volume":"46","author":"van Doorn","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.bjid.2018.06.005_bib0190","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gut.48.6.743","article-title":"The importance of interleukin 1beta in Helicobacter pylori associated disease","volume":"48","author":"El-Omar","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.bjid.2018.06.005_bib0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/35083631","article-title":"The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer","volume":"412","author":"El-Omar","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bjid.2018.06.005_bib0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1542-3565(03)00288-X","article-title":"Polymorphism of interleukin-1beta affects the eradication rates of Helicobacter pylori by triple therapy","volume":"2","author":"Furuta","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2018.06.005_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00042737-199701000-00002","article-title":"Current European concepts in the management of Helicobacter pylori infection \u2013 the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG)","volume":"9","author":"Malfertheiner","year":"1997","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.bjid.2018.06.005_bib0210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2133\/dmpk.20.153","article-title":"Influence of CYP2C19 pharmacogenetic polymorphism on proton pump inhibitor-based therapies","volume":"20","author":"Furuta","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1016\/j.bjid.2018.06.005_bib0215","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/S0004-28032011000400008","article-title":"Helicobacter pylori antibiotic resistance in Brazil: clarithromycin is still a good option","volume":"48","author":"Eisig","year":"2011","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/j.bjid.2018.06.005_bib0220","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1128\/AAC.46.6.2021-2023.2002","article-title":"Helicobacter pylori primary resistance to metronidazole and clarithromycin in Brazil","volume":"46","author":"Prazeres Magalhaes","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2018.06.005_bib0225","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1590\/S0036-46652014000300003","article-title":"Resistance to amoxicillin, clarithromycin and ciprofloxacin of Helicobacter pylori isolated from Southern Brazil patients","volume":"56","author":"Picoli","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"10.1016\/j.bjid.2018.06.005_bib0230","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1073\/pnas.0126614100","article-title":"Color and genomic ancestry in Brazilians","volume":"100","author":"Parra","year":"2003","journal-title":"Proc Natl Acad Sci U SA"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867018301892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867018301892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T15:13:49Z","timestamp":1720451629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867018301892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1413867018301892"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2018.06.005","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helicobacter pylori eradication: influence of interleukin-1beta \u201331 C\/T polymorphism","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2018.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}